IMPROVE score: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
Click on the page you are looking for:
{{SI}}
{{CMG}}; {{AE}} {{Rim}}


* [[IMPROVE bleeding risk score]]
==Overview==
The IMPROVE score for [[venous thromboembolism]] (VTE) assesses the risk of VTE among hospitalized medical patients.  The MPROVE predictive score for VTE includes 4 independent risk factors for VTE which are present at admission.  The IMPROVE associative score for VTE includes 7 variables present either at admission or during hospitalization; however the timing of the presence of some of the factors compared to the onset of VTE was not available.<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>


* [[IMPROVE predictive score for VTE]]: IMPROVE predictive risk score assesses the risk of VTE among hospitalized medical patients.  It includes 4 independent risk factors for VTE which are present at admission.<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
==IMPROVE Predictive Score for VTE==
===Calculation of the IMPROVE Predictive Score===
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 3
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Malignancy]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|}


* [[IMPROVE associative score for VTE]]: IMPROVE associative risk score assesses the risk of VTE among hospitalized medical patients. It includes 7 variables present either at admission or during hospitalization; however the timing of the presence of some of the factors compared to the onset of VTE was not available.<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
===Interpretation of the IMPROVE Predictive Score===
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.5%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.0%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.7%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3.1%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5.4%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5-8|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |11%
|}
 
==IMPROVE Associative Score for VTE==
IMPROVE associative risk score assesses the risk of VTE among hospitalized medical patients. While the IMPROVE predictive score includes 4 independent risk factors for VTE which are present at admission, IMPROVE associative score includes 7 variables present either at admission or during hospitalization; however the timing of the presence of some of the factors compared to the onset of VTE is not available.<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
 
===Calculation of the IMPROVE Associative Score===
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 3
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Paralysis of the lower extremity during the hospitalization||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Current [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Immobilization for at least 7 days|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[ICU]] or [[CCU]] admission|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|}
 
===Interpretation of the IMPROVE Associative Score===
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.4%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.6%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.0%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.7%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2.9%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5-10|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |7.2%
|}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Cardiology]]
[[Category:UpToDate]]

Revision as of 00:09, 27 May 2014

WikiDoc Resources for IMPROVE score

Articles

Most recent articles on IMPROVE score

Most cited articles on IMPROVE score

Review articles on IMPROVE score

Articles on IMPROVE score in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on IMPROVE score

Images of IMPROVE score

Photos of IMPROVE score

Podcasts & MP3s on IMPROVE score

Videos on IMPROVE score

Evidence Based Medicine

Cochrane Collaboration on IMPROVE score

Bandolier on IMPROVE score

TRIP on IMPROVE score

Clinical Trials

Ongoing Trials on IMPROVE score at Clinical Trials.gov

Trial results on IMPROVE score

Clinical Trials on IMPROVE score at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on IMPROVE score

NICE Guidance on IMPROVE score

NHS PRODIGY Guidance

FDA on IMPROVE score

CDC on IMPROVE score

Books

Books on IMPROVE score

News

IMPROVE score in the news

Be alerted to news on IMPROVE score

News trends on IMPROVE score

Commentary

Blogs on IMPROVE score

Definitions

Definitions of IMPROVE score

Patient Resources / Community

Patient resources on IMPROVE score

Discussion groups on IMPROVE score

Patient Handouts on IMPROVE score

Directions to Hospitals Treating IMPROVE score

Risk calculators and risk factors for IMPROVE score

Healthcare Provider Resources

Symptoms of IMPROVE score

Causes & Risk Factors for IMPROVE score

Diagnostic studies for IMPROVE score

Treatment of IMPROVE score

Continuing Medical Education (CME)

CME Programs on IMPROVE score

International

IMPROVE score en Espanol

IMPROVE score en Francais

Business

IMPROVE score in the Marketplace

Patents on IMPROVE score

Experimental / Informatics

List of terms related to IMPROVE score

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

The IMPROVE score for venous thromboembolism (VTE) assesses the risk of VTE among hospitalized medical patients. The MPROVE predictive score for VTE includes 4 independent risk factors for VTE which are present at admission. The IMPROVE associative score for VTE includes 7 variables present either at admission or during hospitalization; however the timing of the presence of some of the factors compared to the onset of VTE was not available.[1]

IMPROVE Predictive Score for VTE

Calculation of the IMPROVE Predictive Score

Variable Score[1]
Prior episode of VTE 3
Thrombophilia 3
Malignancy 1
Age more than 60 years 1

Interpretation of the IMPROVE Predictive Score

Score Predicted VTE risk through 3 months[1]
0 0.5%
1 1.0%
2 1.7%
3 3.1%
4 5.4%
5-8 11%

IMPROVE Associative Score for VTE

IMPROVE associative risk score assesses the risk of VTE among hospitalized medical patients. While the IMPROVE predictive score includes 4 independent risk factors for VTE which are present at admission, IMPROVE associative score includes 7 variables present either at admission or during hospitalization; however the timing of the presence of some of the factors compared to the onset of VTE is not available.[1]

Calculation of the IMPROVE Associative Score

Variable Score[1]
Prior episode of VTE 3
Thrombophilia 2
Paralysis of the lower extremity during the hospitalization 2
Current malignancy 2
Immobilization for at least 7 days 1
ICU or CCU admission 1
Age more than 60 years 1

Interpretation of the IMPROVE Associative Score

Score Predicted VTE risk through 3 months[1]
0 0.4%
1 0.6%
2 1.0%
3 1.7%
4 2.9%
5-10 7.2%

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.